Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cadaveric donor selection and management.

Sean M Studer1, Jonathan B Orens

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Seminars in Respiratory and Critical Care Medicine
|October 31, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utility of donor-derived cell-free DNA testing after lung transplantation in the precision medicine era.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Early post-transplant recipient tissue injury predicts allograft function, rejection and survival in lung transplant recipients: evidence from cell-free DNA.

The European respiratory journal·2025
Same author

Sustained Molecular Allograft Injury After Episodes of Acute Rejection and Organizing Pneumonia Increases the Risk of Lung Allograft Failure.

Transplantation direct·2025
Same author

Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same author

Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2025
Same author

Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2025
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Improving lung donor selection and utilization is crucial due to organ shortages. Utilizing extended criteria donors may increase transplants but requires further study on post-transplant outcomes.

Area of Science:

  • Transplantation Medicine
  • Pulmonology
  • Organ Donation

Background:

  • Limited donor lungs available for patients needing lung transplantation.
  • Current criteria for selecting the ideal lung donor are not well-defined.
  • Increased donor awareness alone is insufficient to meet demand.

Purpose of the Study:

  • To summarize the approach to identifying potential lung donors.
  • To outline optimal donor management strategies.
  • To assess the clinical importance of donor factors on recipient outcomes.

Main Methods:

  • Review of current practices in donor identification and management.
  • Analysis of factors influencing donor lung utilization.
  • Discussion of extended criteria donor utilization.

Related Experiment Videos

Main Results:

  • Active participation of transplant teams in donor management can improve utilization.
  • Extended criteria donors offer a potential to increase organ availability.
  • Further research is needed to evaluate risks associated with extended criteria donors.

Conclusions:

  • Optimizing donor selection and management is key to improving lung transplant outcomes.
  • Expanding the use of extended criteria donors requires careful evaluation of risks and benefits.
  • Addressing the lung organ shortage necessitates improved donor utilization strategies.